Semi-Annual Statement Of Income And Retained Earnings

Nxera Pharma Co., Ltd. - Filing #7272710

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-4,624,000,000 JPY
-335,000,000 JPY
Non-operating income
Non-operating income
3,335,000,000 JPY
132,000,000 JPY
Non-operating expenses
Non-operating expenses
256,000,000 JPY
3,098,000,000 JPY
Ordinary profit (loss)
-1,545,000,000 JPY
-3,301,000,000 JPY
Extraordinary income
Extraordinary income
3,696,000,000 JPY
7,000,000 JPY
Profit (loss) before income taxes
2,151,000,000 JPY
-3,294,000,000 JPY
Income taxes - current
7,000,000 JPY
-9,000,000 JPY
Profit (loss)
2,144,000,000 JPY
2,144,000,000 JPY
2,144,000,000 JPY
-3,285,000,000 JPY
-3,285,000,000 JPY
-3,285,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.